Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
G1 Therapeutics Inc
(NQ:
GTHX
)
3.630
-0.010 (-0.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
986,363
Open
3.600
Bid (Size)
3.520 (5)
Ask (Size)
3.700 (5)
Prev. Close
3.640
Today's Range
3.505 - 3.730
52wk Range
1.080 - 6.140
Shares Outstanding
42,705,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025
July 15, 2024
While there’s no denying that G1 Therapeutics stock is highly speculative, investors should still check under the hood.
Via
InvestorPlace
Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble
July 10, 2024
G1 Therapeutics stock is highly volatile, and investors should be wary now as G1 Therapeutics recently failed to achieve a clinical goal.
Via
InvestorPlace
Performance
YTD
+16.72%
+16.72%
1 Month
+43.48%
+43.48%
3 Month
-11.68%
-11.68%
6 Month
+6.14%
+6.14%
1 Year
+49.38%
+49.38%
More News
Read More
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
June 25, 2024
Via
Benzinga
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
June 24, 2024
Via
InvestorPlace
Exposures
Product Safety
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
June 24, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Analyst Ratings For G1 Therapeutics
June 13, 2024
Via
Benzinga
Evaluating G1 Therapeutics: Insights From 5 Financial Analysts
May 01, 2024
Via
Benzinga
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
April 12, 2024
Via
Benzinga
Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge
June 24, 2024
Via
Benzinga
Why Is Cancer-Focused G1 Therapeutics Stock Trading Lower On Monday?
June 24, 2024
Via
Benzinga
Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
June 24, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 24, 2024
Via
InvestorPlace
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)
June 24, 2024
From
G1 Therapeutics
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
May 28, 2024
From
G1 Therapeutics
Via
GlobeNewswire
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024
From
G1 Therapeutics
Via
GlobeNewswire
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
May 22, 2024
From
G1 Therapeutics
Via
GlobeNewswire
What's Going On With G1 Therapeutics Stock?
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
GTHX Stock Earnings: G1 Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 01, 2024
From
G1 Therapeutics
Via
GlobeNewswire
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
May 01, 2024
From
G1 Therapeutics
Via
GlobeNewswire
Biotech Innovations Paving the Way in Breast Cancer Fight
April 11, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.